Conflict of interest: None declared.
The Secondary Prevention of Small Subcortical Strokes (SPS3) study
Article first published online: 26 JAN 2011
© 2011 The Authors. International Journal of Stroke © 2011 World Stroke Organization
International Journal of Stroke
Volume 6, Issue 2, pages 164–175, April 2011
How to Cite
Benavente, O. R., White, C. L., Pearce, L., Pergola, P., Roldan, A., Benavente, M.-F., Coffey, C., McClure, L. A., Szychowski, J. M., Conwit, R., Heberling, P. A., Howard, G., Bazan, C., Vidal-Pergola, G., Talbert, R., Hart, R. G. and for the SPS3 Investigators (2011), The Secondary Prevention of Small Subcortical Strokes (SPS3) study. International Journal of Stroke, 6: 164–175. doi: 10.1111/j.1747-4949.2010.00573.x
Funding: SPS3 is an investigator initiated study funded by a cooperative agreement from the National Institute of Neurological Disorders and Stroke of United States (Grant #2 U01 NS38529-04A1). Together with members of the SPS3 Executive and Steering Committees, NINDS project officers directly participate in the execution of the study and oversee the progress. The clopidogrel and matching placebo have been donated by Sanofi-Aventis and Bristol-Myers Squibb. Neither company has any involvement with the design, execution, or analysis of the trial.
- Issue published online: 4 MAR 2011
- Article first published online: 26 JAN 2011
Options for accessing this content:
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.